Inquiries Lampard Inquiry Hearings ongoing Core Participants · Terminology

Documents

1213 documents published by the inquiry: transcripts, statements, exhibits, rulings and more. Filter by type, hearing day or witness.

Search inside documents →
EPUT020827_KSZT01-096 EPUT Board of Directors - Part 2_ Agenda Item 7a Oxehealth Digital Care As
Open on inquiry site
Other · Day 61
EPUT020830_KSZT01-094 EPUT Board of Directors Part 2_ Agenda Item 8b PHSO and HSE Steering Group
Open on inquiry site
Other · Day 61
BSI028561_Witness Statement of Graeme Tunbridge
Open on inquiry site
Witness Statement · Day 64
MHRA025423_RR1-9 Internal MHRA email chain regarding reportable incident on Oxehealth
Open on inquiry site
Other · Day 64
MHRA025425_RR1-7 Internal MHRA emails regarding Oxehealth advertising material
Open on inquiry site
Other · Day 64
MHRA025435_RR1-5A Oxehealth Response to MHRA Questions
Open on inquiry site
Other · Day 64
MHRA025443_RR1-3A NHS NRLS analysis summary regarding oxehealth and oxevision
Open on inquiry site
Other · Day 64
MHRA025447_RR1-2C Oxehealth Declaration of Conformity according to Medical Devices Directive
Open on inquiry site
Other · Day 64
MHRA025461_RR1-17 MHRA No Objection letter signed by Heloise Mignot
Open on inquiry site
Other · Day 64
MHRA025464_RR1-13 Email chain between Oxehealth Chris Hannan and MHRA Hafsa Sirad regarding medical device qu…
Open on inquiry site
Other · Day 64
MHRA025471_RR1-12 MHRA emails regarding Oxevision activity tracker
Open on inquiry site
Other · Day 64
MHRA025474_RR1-1 Email chain requesting the Instruction For Use material for Oxehealth devices
Open on inquiry site
Other · Day 64
MHRA028025_Second Witness Statement of Robert Reid
Open on inquiry site
Witness Statement · Day 64
MHRA028127_First Witness Statement of Robert Reid on behalf of MHRA
Open on inquiry site
Witness Statement · Day 64
NHSE028936_PS012 Email from MHRA to NHSE re questions for Oxehealth
Open on inquiry site
Other · Day 64
NHSE028957_PS014 Emails between NHSE and MHRA regarding Oxevision responses
Open on inquiry site
Other · Day 64
NHSE028965_PS013 Oxehealth response to MHRA Questions
Open on inquiry site
Other · Day 64
NHSE028974_PS015 Email to NHSE Mental Health team sharing NRLS report following meeting
Open on inquiry site
Other · Day 64
ONLINE SOURCE Regulation 2 of the Medical Devices Regulations 2002
Open on inquiry site
Other · Day 64
OXHE005087_LC3.7 Oxevision Activity Tracker IFU Version 5
Open on inquiry site
Other · Day 64
Restriction Order No.37 – October 2026 Hearing Evidence Disclosure – Tranche 8
Open on inquiry site
Other
EPUT026149_KSZT01-184 Standard Operating Procedure for the use of the LIO platform version 13.4
Open on inquiry site
Other · Day 63
EPUT026141_Supplementary Statement of Dr Kallur Suresh and Zephan Trent
Open on inquiry site
Other · Day 63
EPUT024165_KSZT01-135 EPUTOxehealth Data Protection Impact Assessment DPIA v.24
Open on inquiry site
Other · Day 63
EPUT023598_KSZT01-176g DRAFT EPUT - TIAA Assurance Review of Follow Up of Consent Oxevision
Open on inquiry site
Other · Day 63
EPUT023595_Witness Statement of Dr Kallur Suresh and Zephan Trent
Open on inquiry site
Witness Statement · Day 63
Searchable OCR
EPUT023593_KSZT01-176 EPUT Executive Committee Summary Report Re Rapid Review Briefing Report on
Open on inquiry site
Other · Day 63
EPUT020913_KSZT01-008 EPUT - TIAA Assurance Review of Consent for Oxevision Report
Open on inquiry site
Other · Day 63
EPUT020910_KSZT01-013 EPUT Finance Performance Committee Agenda Item 8 Analysis of Ligature Risk
Open on inquiry site
Other · Day 63
EPUT020850_KSZT01-075 EPUT Board of Directors Part 2 - Summary Report Re Update on Oxevision
Open on inquiry site
Other · Day 63
CTI Paper - Summary of Evidence of Regulators
Open on inquiry site
Counsel to the Inquiry Summary · Day 64
CTI Closing Statement October 2026
Open on inquiry site
Closing StatementCounsel to the Inquiry Summary · Day 64
20220629 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20211214 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20200211 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20171109 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20170523 NG69 NICE guideline
Open on inquiry site
Other
Searchable
20160211 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20150409 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20150121 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20140924 CG185 NICE guideline
Open on inquiry site
Other
Searchable
20140212 CG178 NICE guideline
Open on inquiry site
Other
Searchable
20130107 CG155 NICE Guideline
Open on inquiry site
Other
Searchable
20090128 CG77 NICE guideline
Open on inquiry site
Other
Searchable
20220701 CG133 NICE guideline
Open on inquiry site
Other
Searchable
20180724 CG16 NICE guideline
Open on inquiry site
Other
Searchable
20130418 CG38 NICE guideline
Open on inquiry site
Other
Searchable
20110207 CG82 NICE guideline
Open on inquiry site
Other
Searchable
20090325 CG82 NICE guideline
Open on inquiry site
Other
Searchable
20040128 CG9 NICE guideline
Open on inquiry site
Other
Searchable